Genetically Modified Cells Learn to Fight Mesothelioma
November 5, 2014
(Los Angeles Times) – It’s been called the “fifth pillar” of cancer treatment: genetically reengineering the human immune system to recognize cancers and fight them. The treatment has shown recent promise in fighting blood cancers such as leukemia. But hard tumors, such as mesothelioma, have proven to be more resistant to attack from these tinkered T cells when they were reinjected into the bloodstream.